PILLCARE PHARMA LIMITED

Company Registration Number:
14591726 (England and Wales)

Unaudited abridged accounts for the year ended 31 January 2026

Period of accounts

Start date: 01 February 2025

End date: 31 January 2026

PILLCARE PHARMA LIMITED

Contents of the Financial Statements

for the Period Ended 31 January 2026

Balance sheet
Notes

PILLCARE PHARMA LIMITED

Balance sheet

As at 31 January 2026


Notes
2026
2025


£
£
Called up share capital not paid: 0 0
Fixed assets
Intangible assets: 3 1,259,675 1,332,070
Tangible assets: 4 10,547 14,062
Total fixed assets: 1,270,222 1,346,132
Current assets
Stocks: 90,000 90,000
Debtors:   413,039 361,548
Cash at bank and in hand: 942,356 747,055
Total current assets: 1,445,395 1,198,603
Creditors: amounts falling due within one year:   (987,712) (1,029,485)
Net current assets (liabilities): 457,683 169,118
Total assets less current liabilities: 1,727,905 1,515,250
Creditors: amounts falling due after more than one year:   (1,701,254) (1,485,478)
Total net assets (liabilities): 26,651 29,772
Capital and reserves
Called up share capital: 100 100
Profit and loss account: 26,551 29,672
Shareholders funds: 26,651 29,772

The notes form part of these financial statements

PILLCARE PHARMA LIMITED

Balance sheet statements

For the year ending 31 January 2026 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 29 October 2026
and signed on behalf of the board by:

Name: Amit Aggarwal
Status: Director

The notes form part of these financial statements

PILLCARE PHARMA LIMITED

Notes to the Financial Statements

for the Period Ended 31 January 2026

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Financial Reporting Standard 101

PILLCARE PHARMA LIMITED

Notes to the Financial Statements

for the Period Ended 31 January 2026

2. Employees

2026 2025
Average number of employees during the period 18 18

PILLCARE PHARMA LIMITED

Notes to the Financial Statements

for the Period Ended 31 January 2026

3. Intangible Assets

Total
Cost £
At 01 February 2025 1,447,902
At 31 January 2026 1,447,902
Amortisation
At 01 February 2025 115,832
Charge for year 72,395
At 31 January 2026 188,227
Net book value
At 31 January 2026 1,259,675
At 31 January 2025 1,332,070

PILLCARE PHARMA LIMITED

Notes to the Financial Statements

for the Period Ended 31 January 2026

4. Tangible Assets

Total
Cost £
At 01 February 2025 15,495
At 31 January 2026 15,495
Depreciation
At 01 February 2025 1,433
Charge for year 3,515
At 31 January 2026 4,948
Net book value
At 31 January 2026 10,547
At 31 January 2025 14,062